Showing results (231-240 of 319) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2024
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO GuidelineVan K Morris, Erin B Kennedy, Manik A Amin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das, Edward H Lin, Sumita Bhatia, et al.
Cancer|December 23, 2023
Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancerLauren M Janczewski, Amanda Browner, Joseph Cotler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesJean-Nicolas Vauthey, Timothy M Pawlik, Dario Ribero, et al.
JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
Nature Reviews. Cancer|February 20, 2025
Defining a 'cells to society' research framework for appendiceal tumoursAndreana N Holowatyj, Michael J Overman, Konstantinos I Votanopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistanceScott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.
Pageof 32